CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...
Phase 3
Westwood, Kansas, United States and 23 other locations
study of five dose levels of APVO436 in combination with venetoclax and azacitidine (ven/aza) in adult patients with newly diagnosed, CD123+ AML...
Phase 1
Fairway, Kansas, United States and 6 other locations
AML that cannot or elect not to be treated with more intensive chemotherapy; (2) whether BP1001-based treatment provides greater efficacy (....
Phase 2
Fairway, Kansas, United States and 8 other locations
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
Kansas City, Missouri, United States and 85 other locations
Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...
Phase 1
Fairway, Kansas, United States and 43 other locations
in combination with venetoclax for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults who ar...
Phase 1, Phase 2
Kansas City, Missouri, United States and 33 other locations
This is a multi-center, randomized, double-blinded, placebo controlled trial.
Phase 3
Westwood, Kansas, United States and 104 other locations
An open-label, phase I, multi-center study to determine in relapsed/refractory (r/r) acute myeloid leukemia (AML)...
Phase 1
Fairway, Kansas, United States and 4 other locations
safe and if they have beneficial effects in treating patients with acute myeloid leukemia (AML) or acute ...
Phase 1
Kansas City, Missouri, United States and 5 other locations
it is safe for participants with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). It will study S...
Phase 1
Kansas City, Kansas, United States and 55 other locations
Clinical trials
Research sites
Resources
Legal